EUCTR2008-007519-34-SE进行中（未招募）1 期
Feasibility of Accelerated infliximab infusions - Safety and Tolerability in patients wit IBD. FAST - FAST VERSIO
niversity of Leuven Hospitals, Division of Gastroenterology0 个研究点目标入组 50 人开始时间: 2009年3月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients age 18-80 years
- •Mb Crohn disease or Ulcerative colitis or IBD
- •Already on infliximab therapy treated with one hour infusion
- •sustained clinical respone to infliximab
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Documentation of suspected immediated or delayed infusion reaction to previous infliximab infusion.
- •Prophylactic therapy before infliximab infusion to prevent infusion reaction including corticosteroids, antihistamines and acetaminophen.
- •Need for dose increase or decrease of interval below 6 weeks for loss of response
- •Dosing interval longer than 12 weeks in the previous 12 months
- •Known allergic reactions to any theraputic protein or to murine proteins
- •Any other contraindication to infliximabtherapy at the time of screening
研究者
相似试验
招募中
2 期
The feasibility study of accelated infliximab infusion from initial administratiopatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000015297Chiba University Hospital54
已完成
2 期
The feasibility study of accelated infliximab infusion during maintenance phasepatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000007806Chiba University Hospital54
进行中（未招募）
1 期
Accelerated infliximab infusions in inflammatory bowel diseaseInflammatory bowel diseasesEUCTR2021-000570-28-FITampere University Hospital130
已完成
4 期
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)Crohn's DiseaseUlcerative ColitisNCT01346826Asan Medical Center145
已完成
不适用
Possibilities of measuring Infliximab in patients with Ulcerative Colitis or Crohn's ColitisInflammatory Bowel Diseases10017969NL-OMON37225Academisch Medisch Centrum12